# GRI Bio, Inc.: Form 8-K, filed May 23, 2025

- Company: [GRI Bio, Inc.](/companies/gri.md) (CIK 1824293)
- Form: 8-K
- Filed: 2025-05-23
- Accepted by EDGAR: May 23, 2025, 07:16 ET
- Period: 2025-05-23
- Accession: 0001824293-25-000079
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1824293/000182429325000079/val-20250523.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1824293/000182429325000079/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1824293/000182429325000079/val-20250523.htm

Filed May 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001824293-25-000079. Last ingested by Listed: Nov 14, 2026, 23:49 ET. No prices; not investment advice.
